Novartis Diovan heart study retracted; Almac, Queen's University partner on cancer-drug discovery;

@FierceBiotech: In growing diabetes market, Sanofi looks beyond iPhone for mobile glucose testing. Article from FierceBiotech IT | Follow @FierceBiotech

@JohnCFierce: Crowdfunding cash for biotech startup Perle (diabetes). Press release | Follow @JohnCFierce

@Ry_McBride: UPDATED: No end of biotech IPO frenzy in sight. Special report | Follow @Ry_McBride

@EmilyMFierce: Making iPS cells safer for use in humans through the study of a cellular odd fellow. More from Stanford | Follow @EmilyMFierce

> U.K.-based Almac Discovery has announced a £13 million ($20.3 million) partnership with the Centre for Cancer Research and Cell Biology (CCRCB) at Queen's University Belfast to accelerate cancer-focused drug discovery in Northern Ireland. Release

> The medical journal The Lancet has formally retracted the Novartis ($NVS) Diovan Jikei Heart Study paper, originally published in 2007. Story

> Researchers used induced pluripotent stem cells to identify kidney disease defect, and the findings point to a new potential strategy for preventing and treating the disease. Release

Pharma News

@FiercePharma: Glaxo said to be near $1.6B Lucozade-Ribena sale to Japan's Suntory. Latest in series of brand sales. ICYMI yesterday | Follow @FiercePharma

@EricPFierce: Bristol-Myers Squibb flees high cost of East Coast with new center in Tampa, FL. Moving some jobs from NJ. Report | Follow @EricPFierce

@CarlyHFierce: Departure of new Vivus CEO Zook tops the list of this week's hirings, firings & other movements in pharma/biotech. Chutes & Ladders | Follow @CarlyHFierce

> Would GSK pull out of China altogether? More

> 'Doctor-2' in Elan, Wyeth insider trading case said to be well connected Alzheimer's doc. Article

> Another compounder recalls drugs because of lapse in outside testing. Story

Medical Device News

@FierceMedDev: Enzymatics jumps into next-gen Dx space with $50M startup buy. More | Follow @FierceMedDev

@MarkHFierce: Better sanitation is linked to more Alzheimer's cases. Article | Follow @MarkHFierce

@MichaelGFierce: Myriad rolls out next-gen Dx for 8 major cancers. Story | Follow @MichaelGFierce

> Rented Medtronic tools linked to possible disease exposure. News

> Enzymatics jumps into next-gen Dx space with $50M startup buy. Report

> Report: KKR favored bidder in Panasonic's billion-dollar health unit sale. Story

> India advances effort to modernize medical device regs. Item

And Finally... Just for kicks, check out this bizarre-looking web structure in the Peruvian Amazon that is mystifying scientists.

Suggested Articles

EQRx is adding a pair of PD-1/PD-L1 meds to its pipeline through a deal with CStone worth $150 million upfront but could net the latter $1.15 billion.

All eyes are on Pfizer’s COVID-19 vaccine work, but the Big Pharma has today quietly culled two midstage trials and one phase 1 test.

All subjects had lower extremity weakness after receiving antisense oligonucleotide GTX-102, leading Ultragenyx to pause the study.